Home›People›Patrick Barry
PB

Patrick Barry

Chief Commercial Officer at Indivior Pharmaceuticals. Also an executive vice president; president, global commercial operations at Endo.

ExecutivePublic company
Updated Nov 2, 2026·Latest SEC filing Feb 12, 2026·Suggest an edit

About Patrick Barry

Patrick Barry is a chief commercial officer at Indivior Pharmaceuticals.

Form D filings name Patrick Barry as an executive vice president; president, global commercial operations at Endo.

Patrick Barry reports to the SEC as an officer of 2 public companies, including Endo International plc (ENDP).

Patrick Barry first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Patrick Barry in the role, so the role may have started earlier or lasted longer.

Indivior Pharmaceuticals, Inc.
Chief Commercial Officer
2026 · Public company (INDV)
Endo, Inc.
Executive Vice President; President, Global Commercial Operations
2024 · Malvern, PA
Endo International plc
EVP & Pres,Global Comm Ops
2018 – 2022 · Public company (ENDP)

Key Colleagues at Startups

The people Patrick Barry works with at each company, as listed on that company's latest Form D.

Endo, Inc. · Form D/A, May 6, 2024
SH
Scott Hirsch
Director
PE
Paul Efron
Director
PH
MY
BC
Blaise Coleman
President; Chief Executive Officer and director
MM
Matthew Maletta
Executive Vice President; Chief Legal Officer; Secretary
SL
FR
Frank Raciti
Vice President; Controller; Chief Accounting Officer
MB
Mark Bradley
Executive Vice President; Chief Financial Officer and director
AP

Sources

  1. SECEndo, Inc. Form D/A, filed May 6, 2024
  2. SECForms 3, 4 and 5 filed by Patrick Barry (SEC filer 1733376)